Lung Cancer Clinical Trial

Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice

Summary

This is an observational, multicenter study in participants treated with nivolumab for the approved indications of melanoma and Lung cancer in Australia, the EU, Switzerland, the United Kingdom (UK), and the United States (US). The targeted countries in the EU for study participation include Austria, Belgium, Czech Republic, France, Germany, Hungary, Italy, Poland, and Spain. Study objectives are to assess the safety experience, survival, adverse event management, and outcomes of adverse events associated with nivolumab in routine oncology care facilities.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age ≥18
Histologically or cytologically confirmed diagnosis of melanoma (including uveal melanoma) or lung cancer
Treatment with commercial nivolumab for the first time, alone or in combination with ipilimumab, for the approved indications of nivolumab within 14 days before informed consent for this study OR in the case where treatment has not yet been initiated, documentation that the treatment strategy is determined before an informed consent to study participation, and treatment is initiated within 28 days after informed consent

Exclusion Criteria:

Prior participation in a clinical trial within the past 4 weeks
Previously treated with anti-PD-1, anti-PD-L1, or anti-PD-L2 antibodies
Previously treated with anti-CTLA-4 for lung cancer
Current or pending participation in a clinical trial
Current or pending systemic treatment for cancer other than melanoma and lung cancer
Inability to comply with the study protocol

Study is for people with:

Lung Cancer

Estimated Enrollment:

1189

Study ID:

NCT02847728

Recruitment Status:

Completed

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 93 Locations for this study

See Locations Near You

Local Institution - 1909
Palm Springs California, 92262, United States
Local Institution - 1912
Jacksonville Florida, 32204, United States
Local Institution - 1907
Lake City Florida, 32024, United States
Local Institution - 1901
Park Ridge Illinois, 60068, United States
Local Institution - 1910
Alexandria Louisiana, 71301, United States
Local Institution - 1906
Tupelo Mississippi, 38801, United States
Local Institution - 1908
Kansas City Missouri, 64108, United States
Local Institution - 1911
Morristown New Jersey, 07962, United States
Local Institution - 1902
Bethlehem Pennsylvania, 18015, United States
Local Institution - 1913
Hilton Head Island South Carolina, 29926, United States
Local Institution - 1915
El Paso Texas, 79920, United States
Local Institution - 1905
Fort Sam Houston Texas, 78234, United States
Local Institution - 1001
Lismore New South Wales, 2480, Australia
Local Institution - 1002
Wagga Wagga New South Wales, 2650, Australia
Local Institution - 1006
Franskton Victoria, 3199, Australia
Local Institution - 1003
Wodonga Victoria, 3690, Australia
Local Institution - 1005
Subiaco Western Australia, 6008, Australia
Local Institution - 1103
Innsbruck , 6020, Austria
Local Institution - 1102
Klagenfurt Am Woerthersee , 9020, Austria
Local Institution - 1101
Krems an der Donau , 3500, Austria
Local Institution - 1202
Brasschaat Antwerpen, 2930, Belgium
Local Institution - 1203
Kortrijk , 8500, Belgium
Local Institution - 1201
Namur , 5000, Belgium
Local Institution - 2002
Olomouc , 779 0, Czechia
Local Institution - 1307
Lyon , 69229, France
Local Institution - 1301
Metz-Tessy , 74374, France
Local Institution - 1305
Nancy , 54100, France
Local Institution - 1304
Saint Jean Priest En Jarez , 42277, France
Local Institution - 1303
Toulouse , 31059, France
Local Institution - 1302
Vandoeuvre-les-Nancy , 54519, France
Local Institution - 1429
Heidelberg Baden-Württemberg, 69120, Germany
Local Institution - 1430
Greifswald Mecklenburg-Vorpommern, 17475, Germany
Local Institution - 1434
Koblenz Rheinland Pfa, 56068, Germany
Local Institution - 1401
Quedlinburg Sachsen-Anhalt, 06484, Germany
Local Institution - 1410
Luebeck Schleswig-Holstein, 23538, Germany
Local Institution - 1403
Augsburg , 86156, Germany
Local Institution - 1423
Ballenstedt , 06493, Germany
Local Institution - 1427
Berlin , 10117, Germany
Local Institution - 1411
Bochum , 44791, Germany
Local Institution - 1436
Bonn , 53115, Germany
Local Institution - 1413
Bremerhaven , 27574, Germany
Local Institution - 1407
Buxtehude , 21614, Germany
Local Institution - 1419
Cologne , 51109, Germany
Local Institution - 1417
Erfurt , 99089, Germany
Local Institution - 1416
Gera , 07548, Germany
Local Institution - 1428
Giessen , 35385, Germany
Local Institution - 1422
Hamburg , 20246, Germany
Local Institution - 1424
Hamburg , 22081, Germany
Local Institution - 1408
Jena , 07743, Germany
Local Institution - 1406
Kassel , 34125, Germany
Local Institution - 1425
Leipzig , 04103, Germany
Local Institution - 1432
Ludwigshafen , 67063, Germany
Local Institution - 1433
Mainz , 55101, Germany
Local Institution - 1426
Mainz , 55131, Germany
Local Institution - 1405
Minden , 32429, Germany
Local Institution - 1431
Muenchen , 80335, Germany
Local Institution - 1409
München , 80336, Germany
Local Institution - 1420
Münster , 48157, Germany
Local Institution - 1418
Recklinghausen , 45657, Germany
Local Institution - 1402
Regensburg , 93042, Germany
Local Institution - 1415
Rostock , 18107, Germany
Local Institution - 1421
Rostock , 18107, Germany
Local Institution - 1435
Saarbrucken , 66113, Germany
Local Institution - 1414
Schwerin , 19049, Germany
Local Institution - 1404
Traunstein , 83278, Germany
Local Institution - 1412
Ulm , 89081, Germany
Local Institution - 2101
Gyongyossolymos Heves, 3233, Hungary
Local Institution - 2107
Budapest , 1121, Hungary
Local Institution - 2102
Debrecen , 4032, Hungary
Local Institution - 2106
Farkasgyepu , 8582, Hungary
Local Institution - 2103
Torokbalint , 2045, Hungary
Local Institution - 1501
Bari , 70124, Italy
Local Institution - 1506
Lecce , 73100, Italy
Local Institution - 1505
Lucca , 5510, Italy
Local Institution - 1503
Napoli , 80131, Italy
Local Institution - 1502
Ravenna , 48121, Italy
Local Institution - 1504
Udine , 33100, Italy
Local Institution - 2201
Opole Opolskie, 45-06, Poland
Local Institution - 2202
Gdansk , 80-21, Poland
Local Institution - 2203
Olsztyn , 10-35, Poland
Local Institution - 1904
Bayamon , 00961, Puerto Rico
Local Institution - 1606
Avila , 05004, Spain
Local Institution - 1605
Caceres , 10003, Spain
Local Institution - 1602
Jaen , 23007, Spain
Local Institution - 1601
Madrid , 28033, Spain
Local Institution - 1604
Salamanca , 37007, Spain
Local Institution - 1607
Santander , 39008, Spain
Local Institution - 1603
Toledo , 45004, Spain
Local Institution - 1703
Baden Aargau, 5404, Switzerland
Local Institution - 1702
Locarno , 6600, Switzerland
Local Institution - 1803
Aberdeen Aberdeenshire, AB25 , United Kingdom
Local Institution - 1802
Truro Cornwall, TR1 3, United Kingdom
Local Institution - 1804
Glasgow Strathclyde, G12 0, United Kingdom
Local Institution - 1801
Bristol , BS2 8, United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

1189

Study ID:

NCT02847728

Recruitment Status:

Completed

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.